BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Parapanov R, Debonneville A, Wang Y, Abdelnour‐berchtold E, Gonzalez M, Gronchi F, Perentes J, Ris H, Eckert P, Piquilloud L, Lugrin J, Letovanec I, Krueger T, Liaudet L. Treatment with 3‐aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation. Am J Transplant 2020;20:967-76. [DOI: 10.1111/ajt.15695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Jin X, Kaes J, Van Slambrouck J, Inci I, Arni S, Geudens V, Heigl T, Jansen Y, Carlon MS, Vos R, Van Raemdonck D, Zhang Y, Vanaudenaerde BM, Ceulemans LJ. A Comprehensive Review on the Surgical Aspect of Lung Transplant Models in Mice and Rats. Cells 2022;11:480. [PMID: 35159289 DOI: 10.3390/cells11030480] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang A, Ali A, Keshavjee S, Liu M, Cypel M. Ex vivo lung perfusion for donor lung assessment and repair: a review of translational interspecies models. Am J Physiol Lung Cell Mol Physiol 2020;319:L932-40. [PMID: 32996780 DOI: 10.1152/ajplung.00295.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hasenauer A, Bédat B, Parapanov R, Lugrin J, Debonneville A, Abdelnour-Berchtold E, Gonzalez M, Perentes JY, Piquilloud L, Szabo C, Krueger T, Liaudet L. Effects of cold or warm ischemia and ex-vivo lung perfusion on the release of damage associated molecular patterns and inflammatory cytokines in experimental lung transplantation. J Heart Lung Transplant 2021;40:905-16. [PMID: 34193360 DOI: 10.1016/j.healun.2021.05.015] [Reference Citation Analysis]
4 Arni S, Maeyashiki T, Citak N, Opitz I, Inci I. Subnormothermic Ex Vivo Lung Perfusion Temperature Improves Graft Preservation in Lung Transplantation. Cells 2021;10:748. [PMID: 33805274 DOI: 10.3390/cells10040748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Criner RN, Clausen E, Cantu E. Primary graft dysfunction. Curr Opin Organ Transplant 2021;26:321-7. [PMID: 33938469 DOI: 10.1097/MOT.0000000000000876] [Reference Citation Analysis]
6 Miller CL, O JM, Allan JS, Madsen JC. Novel approaches for long-term lung transplant survival. Front Immunol 2022;13:931251. [DOI: 10.3389/fimmu.2022.931251] [Reference Citation Analysis]
7 Clausen E, Cantu E. Primary graft dysfunction: what we know. J Thorac Dis 2021;13:6618-27. [PMID: 34992840 DOI: 10.21037/jtd-2021-18] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Niroomand A, Hirdman G, Olm F, Lindstedt S. Current Status and Future Perspectives on Machine Perfusion: A Treatment Platform to Restore and Regenerate Injured Lungs Using Cell and Cytokine Adsorption Therapy. Cells 2021;11:91. [PMID: 35011653 DOI: 10.3390/cells11010091] [Reference Citation Analysis]
9 Parapanov R, Wang X, Wang Y, Debonneville A, Lugrin J, Liaudet L, Krueger T. Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion. Transplant Direct 2022;8:e1337. [PMID: 35702630 DOI: 10.1097/TXD.0000000000001337] [Reference Citation Analysis]
10 Prasad NK, Pasrija C, Talaie T, Krupnick AS, Zhao Y, Lau CL. Ex Vivo Lung Perfusion: Current Achievements and Future Directions. Transplantation 2021;105:979-85. [PMID: 33044428 DOI: 10.1097/TP.0000000000003483] [Reference Citation Analysis]
11 Szabo C, Martins V, Liaudet L. Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept. Am J Respir Cell Mol Biol 2020;63:571-90. [PMID: 32640172 DOI: 10.1165/rcmb.2020-0188TR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]